Table 2 IFNγ Specific Human Response (HR>10%) in LD Patients with EM and Healthy Individuals that were WCS Negative
From: IFNγ production in peripheral blood of early Lyme disease patients to hLFAαL (aa326-345)
Lyme Disease patients with EM N.Pos/total (%) | Healthy, WCS neg N.Pos/total (%) | ||||
|---|---|---|---|---|---|
< 1 month | At 3 months | OspA vacc. | LD total | Healthy total | |
hLFAaL(aa326-345) | 4/7 (57%) | 5/9 (56%) | 2/3 (67%) | 11/19 (58%) | 3/15 (20%) |
OspAB31(aa164-183) | 1/7 (14%) | 1/9 (11%) | 0/3 (0%) | 2/19 (11%) | 0/15 (0%) |